In January 2025, Labman announced its largest project to date: the design, construction, and support of an innovative drug discovery platform for a leading global pharmaceutical company. This ...
The AI-optimized BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) platform combines the skills of CPI (UK), Basetwo (Canada), Nicoya (Canada), and Labman ...
Hosted on MSN
Labman leads international project to develop AI-powered bioreactor platform for next-generation biologics
Labman is proud to be involved in a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing using cutting-edge automation, AI, and real-time process control. The ...
Explore how Labman's system has been indispensable in this cutting-edge automated laboratory in California. Image Credit: Labman With over 150,000 new materials developed by the Materials Project ...
This SLAS US 2026 tutorial brings together automation executives from Labman, AstraZeneca, and Alexion to discuss how strategic alliances can speed up the adoption of advanced chemical automation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results